USA Today launches "Most Influential Doctors" database

Share this article:

USA Today launched a web feature May 14 providing consumers with a searchable database of the nation's most influential doctors (MID).

The MID analytics are culled from Wolters Kluwer Health data and compiled by analytics firm Qforma, allowing consumers to identify up to seven local doctors associated with one of four conditions: asthma, diabetes, cholesterol and hypertension.

Doctors' names, addresses and practicing status are reviewed for accuracy by marketing research firm SK&A. The database is provided gratis to USA Today, according to a spokesperson for Qforma MID.

Located at, the MID database “provides new insight into the respected local physicians who care for our readers, using methodology that goes beyond traditional best-doctor rankings,” said Susan Weiss, managing editor for the Life section at USA Today, in a statement.

Doctors are deemed worthy of “most influential” status based on data points including “where they live, what meetings they attend, who they socialize with, what drugs they prescribe, their group practice information, hospital affiliations, leadership positions in professional associations, volume of patients and participation in managed care,” according to a spokesperson.

About 30% of all doctors nationwide qualify as MIDs, although the database displays on average three to five doctors (roughly 6,000 in total) for each condition in each of the 350 metropolitan areas, according to a USA Today report.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Channel

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...